BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 26202443)

  • 21. Variations and trends in the prescription of initial second line therapy for patients with rheumatoid arthritis.
    Galindo-Rodriguez G; Avina-Zubieta JA; Fitzgerald A; LeClerq SA; Russell AS; Suarez-Almazor ME
    J Rheumatol; 1997 Apr; 24(4):633-8. PubMed ID: 9101493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utilization of biologic agents in rheumatoid arthritis in the United States: analysis of prescribing patterns in 16,752 newly diagnosed patients and patients new to biologic therapy.
    Yazici Y; Shi N; John A
    Bull NYU Hosp Jt Dis; 2008; 66(2):77-85. PubMed ID: 18537774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends in disease modifying antirheumatic drug prescription in early rheumatoid arthritis are influenced more by hospital setting than patient or disease characteristics.
    Carli C; Ehlin AG; Klareskog L; Lindblad S; Montgomery SM
    Ann Rheum Dis; 2006 Aug; 65(8):1102-5. PubMed ID: 16322085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists.
    van Roon EN; van den Bemt PM; Jansen TL; Houtman NM; van de Laar MA; Brouwers JR
    Clin Ther; 2009 Aug; 31(8):1737-46. PubMed ID: 19808132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differences in the use of second-line agents and prednisone for treatment of rheumatoid arthritis by rheumatologists and non-rheumatologists.
    Criswell LA; Such CL; Yelin EH
    J Rheumatol; 1997 Dec; 24(12):2283-90. PubMed ID: 9415629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Most rheumatologists are conservative in active rheumatoid arthritis despite methotrexate therapy: results of the PRISME survey.
    Saraux A; Devauchelle-Pensec V; Engerran L; Flipo RM
    J Rheumatol; 2006 Jul; 33(7):1258-65. PubMed ID: 16783865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment and management of rheumatoid arthritis.
    Haraoui B
    J Rheumatol Suppl; 2009 Jun; 82():2-10. PubMed ID: 19509324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of anti-TNF treatment initiation in rheumatoid arthritis databases demonstrates wide country variability in patient parameters at initiation of anti-TNF therapy.
    Pease C; Pope JE; Truong D; Bombardier C; Widdifield J; Thorne JC; Paul Haraoui B; Psaradellis E; Sampalis J; Bonner A
    Semin Arthritis Rheum; 2011 Aug; 41(1):81-9. PubMed ID: 21168187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Smoldering rheumatoid arthritis: is the Canadian healthcare system neglecting a significant disease population?
    Edworthy S; Zummer M; Garner S; Boire G; Leclercq S; Bykerk V; Kraag G; Markland J; Thomas D; Thomson J; Henderson J
    J Rheumatol; 2008 Aug; 35(8):1506-12. PubMed ID: 18597407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Barriers to optimal disease control for rheumatoid arthritis patients with moderate and high disease activity.
    Tymms K; Zochling J; Scott J; Bird P; Burnet S; de Jager J; Griffiths H; Nicholls D; Roberts L; Arnold M; Littlejohn G
    Arthritis Care Res (Hoboken); 2014 Feb; 66(2):190-6. PubMed ID: 23983001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progression of functional disability in patients with rheumatoid arthritis. Associations with rheumatology subspecialty care.
    Ward MM; Leigh JP; Fries JF
    Arch Intern Med; 1993 Oct; 153(19):2229-37. PubMed ID: 8215726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of biologics monotherapy in a cohort of patients with Rheumatoid Arthritis in daily clinical practice.
    Catay E; Bravo M; Rosa J; Soriano ER
    BMC Musculoskelet Disord; 2016 Mar; 17():110. PubMed ID: 26932312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of disease modifying antirheumatic drugs in women with rheumatoid arthritis of childbearing age: a survey of practice patterns and pregnancy outcomes.
    Chakravarty EF; Sanchez-Yamamoto D; Bush TM
    J Rheumatol; 2003 Feb; 30(2):241-6. PubMed ID: 12563675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physician treatment preferences in rheumatoid arthritis of differing disease severity and activity: the impact of cost on first-line therapy.
    Erkan D; Yazici Y; Harrison MJ; Paget SA
    Arthritis Rheum; 2002 Jun; 47(3):285-90. PubMed ID: 12115159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The proposal of the Croatian Society for Rheumatology for the treatment of adult rheumatoid arthritis patients with biologics, 2013].
    Babić-Naglić D; Anić B; Čikeš N; Novak S; Grazio S; Morović-Vergles J; Kehler T; Marasović-Krstulović D; Milanović S; Hanih M; Perić P; Vlak T; Potokič K; Ćurković B;
    Reumatizam; 2013; 60(1):47-51. PubMed ID: 24003685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What matters to patients and physicians when considering biologic therapy for rheumatoid arthritis.
    Lisicki R; Chu L
    Postgrad Med; 2008 Sep; 120(3):154-60. PubMed ID: 18824833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of pregnant and non-pregnant rheumatic patients: a survey among Dutch rheumatologists.
    Vroom F; van de Laar MA; van Roon EN; Brouwers JR; de Jong-van den Berg LT
    J Clin Pharm Ther; 2008 Feb; 33(1):39-44. PubMed ID: 18211615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Are patients with rheumatoid arthritis still at an increased risk of tuberculosis and what is the role of biological treatments?
    Arkema EV; Jonsson J; Baecklund E; Bruchfeld J; Feltelius N; Askling J;
    Ann Rheum Dis; 2015 Jun; 74(6):1212-7. PubMed ID: 24608401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prescribing trends for targeted therapies in rheumatoid arthritis among rheumatologists in Southern California, 2008-2010.
    Bagheri S; Wallace DJ
    Arthritis Rheum; 2011 Nov; 63(11):3641. PubMed ID: 21769837
    [No Abstract]   [Full Text] [Related]  

  • 40. Real-world utilization of DMARDs and biologics in rheumatoid arthritis: the RADIUS (Rheumatoid Arthritis Disease-Modifying Anti-Rheumatic Drug Intervention and Utilization Study) study.
    Gibofsky A; Palmer WR; Goldman JA; Lautzenheiser RL; Markenson JA; Weaver A; Schiff MH; Keystone EC; Paulus HE; Harrison MJ; Whitmore JB; Leff JA
    Curr Med Res Opin; 2006 Jan; 22(1):169-83. PubMed ID: 16393443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.